Does Endometriosis Affect Egg Quality or Implantation?
You Can Replace the Egg. You Cannot Replace the Uterus.
By Andrea Vidali, MD
Fellowship-trained reproductive endocrinologist & endometriosis excision surgeon
The Short Answer
Endometriosis-related infertility is primarily an implantation problem, not an egg quality problem. When women with endometriosis receive eggs from young, healthy donors—which removes egg quality from the equation entirely—they still implant and conceive less often than donor-egg recipients without endometriosis. The deficit therefore comes from the uterus.
-
Implantation with Donor Eggs: 43% with endometriosis vs. 49% without
-
Stepwise Decline by Stage: Implantation rates drop from 44.3% in Stage I to 36.5% in Stage IV
-
Donor Eggs Do Not Normalize Live Birth: Switching to donor eggs does not improve live birth rates in endometriosis patients compared to autologous cycles
-
Egg Quality Component: Real but modest, concentrated primarily in severe disease with ovarian endometriomas
If you have endometriosis and are struggling to conceive, you have almost certainly been told something about your eggs: that your ovarian reserve is low, that the quality is poor, or that donor eggs are your only realistic path forward. It is one of the most common counseling conversations in reproductive medicine—and the clinical evidence has been quietly contradicting it for years.
This question decides whether a patient spends years and substantial financial resources chasing better embryos, or whether attention shifts to the pelvic and uterine environment those embryos must implant into. Getting it backwards costs patients time they do not have.
How Do We Know It Is the Uterus and Not the Eggs?
The Core Logic: Take eggs from a young, healthy, screened donor. Give them to a woman with endometriosis, and give them to a woman without. Egg quality is held constant by design. If the group with endometriosis still experiences lower implantation and pregnancy rates, the deficit cannot be the egg—it must be the recipient’s uterine environment.
The strictest version of this model splits sibling oocytes from a single donor between two recipients (same donor, same lab, same embryologist, differing only by the recipient uterus).
The Donor-Egg Experiment (6,148 First Cycles — ESHRE 2026):
-
Recipients Without Endometriosis (n = 3,561): 49% of embryos implanted, 64% clinical pregnancy rate.
-
Recipients With Endometriosis (n = 2,587): 43% of embryos implanted, 59% clinical pregnancy rate.
-
Note: Miscarriage rates did not differ between the groups. Data source: Shroff et al., ESHRE 2026.
Roughly six percentage points of implantation are lost even when embryo quality is optimal. Whatever is failing is failing after the embryo arrives.
Does Endometriosis Stage Affect Implantation Rates?
Yes. When evaluating donor-egg cycles, implantation falls in a direct stepwise gradient as disease severity increases:
| Endometriosis Stage | Implantation Rate (Donor Eggs) | Difference vs. Stage I Baseline |
|
Stage I (Minimal)
|
44.3% |
Baseline |
|
Stage IV (Severe)
|
36.5% |
-7.8 percentage points
|
|
Control (No Endometriosis)
|
49.5% |
+5.2 percentage points
|
A biological gradient tracking anatomical stage demonstrates that this is genuine pathology rather than statistical noise. When researchers excluded coexisting adenomyosis, the stepwise implantation deficit persisted.
Why Did Reproductive Medicine Believe the Opposite for 30 Years?
Early studies in the 1990s and 2000s that concluded the problem was solely egg quality were severely underpowered. The founding 1994 analysis rested on just eleven donor cycles, and a 2000 follow-up evaluated only 25 patients with severe disease. Small cohorts cannot detect moderate, multi-factorial effects.
When registry datasets expanded to statistical power, the uterine factor became unmistakable:
-
UK National Registry (13,614 cycles, 2022): Switching women with endometriosis to donor eggs did not improve their live birth rates compared to their own eggs.
-
JAMA Network Open Meta-Analysis (100,000+ cycles, 2024): Confirmed a statistically significant deficit in donor-egg recipients with endometriosis.
-
ESHRE Multicentric Analysis (6,148 cycles, 2026): Provided the clearest evidence of an implantation-level block.
Why Does Endometriosis Make Implantation Harder?
The biological pathways impairing implantation in endometriosis include:
-
Progesterone Resistance: The endometrium fails to respond normally to progesterone, remaining in an estrogen-driven, inflammatory state during the implantation window.
-
Gene Silencing: Critical receptivity genes, including HOXA10, are epigenetically suppressed.
-
Missing Receptive Cell Subsets: Single-cell RNA sequencing reveals that specific receptive stromal populations present in healthy tissue are completely absent in women with endometriosis.
(This uterine factor is mirrored in age-related research: a 2026 study of 2,760 donor-egg transfers showed that beyond age 49, live birth dropped and miscarriage rose despite young donor eggs, confirming that uterine biology independently mediates success).
What We Are Not Saying
The oocyte component is not zero. In severe Stage 4 disease with large ovarian endometriomas, toxic oxidative stress within follicular fluid and damage from prior ovarian surgeries can reduce oocyte yield and euploidy.
The accurate clinical formulation is: primarily an implantation problem, modestly an egg problem.
What Should Change in Clinical Counseling
-
Rule 1: An endometriosis diagnosis alone is NOT an indication for donor eggs.
-
Rule 2: Screen rigorously for coexisting adenomyosis using high-resolution 3D imaging.
-
Rule 3: Reassure donor-egg candidates: success rates remain viable (mid-30s to mid-40s%).
-
Rule 4: Euploid embryo implantation failure requires an endometrial and pelvic workup.
Excision Surgery & Fertility: Complete laparoscopic excision removes disease and quenches pelvic inflammation, though it must be integrated into a comprehensive reproductive plan rather than viewed as a solitary cure for lining dysfunction.
Frequently Asked Questions
Does endometriosis affect egg quality?
Only modestly, and primarily in severe Stage 4 disease involving large ovarian endometriomas or surgical scarring. Donor-egg trials prove that when egg quality is held constant, women with endometriosis still experience lower implantation rates, demonstrating that the primary deficit is uterine.
Do I need donor eggs if I have endometriosis?
Not because of the endometriosis diagnosis alone. Donor eggs should be reserved for diminished ovarian reserve or advanced maternal age. Switching to donor eggs does not resolve the implantation barriers caused by endometriosis.
How successful is IVF with donor eggs in women with endometriosis?
Success rates remain favorable, with live birth rates per transfer running between 34% and 44% (approximately 3 to 5 percentage points below controls). Endometriosis modestly reduces donor-egg efficiency, but it does not close the door on successful pregnancy.
Why should I be screened for adenomyosis before embryo transfer?
Adenomyosis frequently coexists with endometriosis and is one of the strongest negative predictors of embryo implantation. It is often missed on routine pelvic ultrasound and requires specialized high-resolution imaging.
My euploid embryos are failing to implant. What is the next step?
Repeated failure with chromosomally normal (euploid) embryos is an implantation issue, not an embryo issue. It warrants a structured workup for pelvic endometriosis, adenomyosis, progesterone resistance, and immune/inflammatory factors before attempting identical transfer cycles.
References & Evidence Base
-
Shroff M, et al. Beyond the eggs: a large-scale multicentric analysis of the impact of endometriosis on clinical pregnancy rates in IVF with donor oocytes. Hum Reprod. 2026;41(Suppl 1) — ESHRE 42nd Annual Meeting abstract.
-
Kamath MS, Subramanian V, Antonisamy B, Sunkara SK. Endometriosis and oocyte quality: an analysis of 13,614 donor oocyte recipient and autologous IVF cycles. Hum Reprod Open. 2022;2022(3):hoac025.
-
Paffoni A, Casalechi M, De Ziegler D, et al. Live birth after oocyte donation in vitro fertilization cycles in women with endometriosis: a systematic review and meta-analysis. JAMA Netw Open. 2024;7(1):e2354249.
-
Crestani B, Massaro MG, Parisi A, Molinaro P, Pellicer A, Cozzolino M. Recipient age and reproductive outcomes in donor oocyte cycles: exploring the potential contribution of uterine aging. J Assist Reprod Genet. 2026.
-
Prapas Y, Goudakou M, Matalliotakis I, et al. History of endometriosis may adversely affect the outcome in menopausal recipients of sibling oocytes. Reprod Biomed Online. 2012;25(5):543–548.
-
Díaz I, Navarro J, Blasco L, Simón C, Pellicer A, Remohí J. Impact of stage III-IV endometriosis on recipients of sibling oocytes. Fertil Steril. 2000;74(1):31–34.
Endometriosis Surgical Specialists International (ESSI)
New York · New Jersey · Miami · internationalendo.com
Medical Disclaimer: This article is strictly educational and does not replace individualized medical advice. Fertility decisions depend on multifaceted clinical factors that require direct consultation with a qualified reproductive endocrinologist.